Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD 459.20
-4.60 (-0.99%)
Nov 11, 2026, 4:08 PM HKT
HKG:6990 Market Cap
HKG:6990 has a market cap or net worth of 109.76 billion as of November 10, 2026. It is the 1,663rd most valuable company in the world and the 84th biggest in Hong Kong. Its market cap has increased by 13.86% in one year.
Market Cap
109.76B
Enterprise Value
104.34B
Revenue
2.41B
Global Rank
Country Rank
#84 Hong Kong
PE Ratio
613.62
ChartMarket Cap Chart
Since July 11, 2023, HKG:6990's market cap has increased from 13.49B to 109.76B, an increase of 713.68%. That is a compound annual growth rate of 87.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 109.76B | 20.01% |
| Dec 31, 2025 | 91.46B | 146.43% |
| Dec 31, 2024 | 37.11B | 64.54% |
| Dec 29, 2023 | 22.56B | 67.21% |
| Jul 11, 2023 | 13.49B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 373.82B |
| WuXi Biologics | 203.63B |
| Innovent Biologics | 153.72B |
| Sino Biopharmaceutical | 98.93B |
| Akeso | 83.86B |
| Genscript Biotech | 77.13B |
| RemeGen | 56.15B |
| 3SBio | 37.71B |